Upregulation of keratinocyte growth factor during T-Cell immunity in the gut mucosa

Annals of the New York Academy of Sciences

Volumn 859, Issue , 1998, Pages 184-187

  Bajaj Elliott, Mona ^a   Pender, Sylvia L F ^a   Poulsom, Richard ^b   Macdonald, Thomas T ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c 3rd Floor Dominion House ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; KERATINOCYTE GROWTH FACTOR; STAPHYLOCOCCUS ENTEROTOXIN; TUMOR NECROSIS FACTOR ALPHA;

CELL RENEWAL; COLON; CONFERENCE PAPER; CONTROLLED STUDY; EPITHELIUM CELL; FETUS; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; INTESTINE MUCOSA; PROTEIN SYNTHESIS REGULATION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0032406337     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11123.x     Document Type: Conference Paper

References (11)

1. 1. MOWAT, A. M. 1992. Intestinal graft-verus-host disease. In Immunology of Gastrointestinal Disease. T. T. MacDonald, Ed.: 105-136. Kluwer Academic Publishers.Dordrecht, The Netherlands.
2. 2. CERF-BENSUSSAN, N., N. BROUSSE, A. JAARY, A. GOULET, Y. REVILLION, C. RICOUR & D. GUY-GRAND 1990. Role of in-vivo activated T cells in the mechanisms of villus atrophy in humans. Study of allograft rejection. Digestion 46: 297-301.
3. 3. ARATO, A., E. SAVILAHTI & I. PATZI. 1994. Crypt hyperplasia related to increased lymphocyte activation in the rectal mucosa of children with ulcerative colitis. Z. Gastroenterol. 32: 483-487.
4. 4. KELLER, K. & H. K. HOCH. 1994. The use of proliferating cell nuclear antigen (PCNA) expression, and intraepithelial lymphocyte count in the differential diagnosis of inflammatory bowel disease. Ital. J. Gastroenterol. 26: 233-237.
5. 5. KUROKOWA, M., K. LYNCH & D. K. PODOLSKY. 1987. Effects of growth factors on intestinal epithelial cell line: Transforming growth factor beta inhibits proliferation and stimulates differentiation. Biochem. Biophys. Res. Commun. 142: 775-784.
6. 6. PLAYFORD, R. J., R. BOULTON, M. A. GHATEI, S. R. BLOOM & N. A. WRIGHT. 1996. Comparison of the effects of transforming growth factor alpha and the epidermal growth factor on gastrointestinal proliferation and hormone release. Digestion 57(5): 362-367.
7. 7. FINCH, P. W., V. PRICOLO, A. Wu & S. D. FINKLESTEIN. 1996. Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology 110: 441-451.
8. 8. BRAUCHLE, M., A. D. MADLENER, K. WAGNER, U. ANGERMAYER, P. H. LAUER, M. HOFSCHNEIDER, M. GREGOR & S. WERNER. 1996. Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am. J. Pathol. 149: 521-529.
9. 9. BAJAJ-ELLIOTT, M., E. J. BREESE, R. POULSOM, P. D. FAIRCLOUGH & T. T. MACDONALD. 1997. Keratinocyte growth factor in inflammatory bowel disease-increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal fibroblasts. Am. J. Pathol. 151: 1469-1476.
10. 10. AUTRUP, H., L. A. BARRETT, F. E. JACKSON, M. L. JESUDASON, G. STONER, P. PHELPS, B. E. TRUMP & C. C. HARRIS. 1978. Explant culture of human colon. Gastroenterology 74: 1248-1257.
11. 11. MACDONALD, T. T. & J. SPENCER. 1988. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J. Exp. Med. 167: 1341-1349.